Clinical Trials Directory

Trials / Completed

CompletedNCT03939377

Osteopathic Procedure on Pain in Palliative Care

Evaluation of an Osteopathic Procedure in the Management of Pain in Palliative Care Patients in a Mobile Palliative Care Support Team (EMASP): Controlled, Randomized, Single-blind Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Centre Hospitalier Intercommunal Creteil · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The culture of the palliative is anchored more and more in France. In 2009, nearly 9 out of 10 French people (89%) believe that palliative care can reduce the suffering of people at the end of their lives. Despite the rise of palliative care in France, their access is not homogeneous between regions. In 2010, it is estimated that 2 French out of 3 likely to receive palliative care could not access it. Palliative care remains essential at the end of the patient's life, as well as for the family and caregivers. The French government has put in place three national palliative care development programs: 2002-2005, 2008-2012, 2015-2018. The last program has unlocked a budget of 190 million euros for their development. It has been estimated from Social Security reimbursements, that the costs per patient over their last years of life are 26,000 euros, for a total of 13.5 million euros. One of the most important aspects of palliative care is the comfort of the patients as well as their feelings in the care. In order to best meet the expectations of cancer patients, some offer early palliative care that is effective in improving both the quality of life of the patient and its life expectancy. Osteopathy is a manual alternative medicine whose goal is to restore the lack of mobility of tissues. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in the reduction of pain in adult patients in palliative care.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire and treatmentEVA questionnaire every day for 7 days. treatment (real or simulated) at J3 and J5

Timeline

Start date
2019-03-01
Primary completion
2021-05-01
Completion
2021-05-01
First posted
2019-05-06
Last updated
2021-06-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03939377. Inclusion in this directory is not an endorsement.